Author:
Kjelby Eirik,Gjestad Rolf,Fathian Farivar,Sinkeviciute Igne,Alisauskiene Renata,Anda Liss-Gøril,Løberg Else-Marie,Reitan Solveig Klæbo,Joa Inge,Larsen Tor Ketil,Rettenbacher Maria,Berle Jan Øystein,Fasmer Ole Bernt,Kroken Rune Andreas,Johnsen Erik
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference19 articles.
1. Letter to the editors: comments on article by Kjelby and colleagues: unraveling the optimal treatment approach for depression in schizophrenia spectrum: a quest for clarity;J Clin Psychopharmacol,2024
2. Antidepressive effectiveness of amisulpride, aripiprazole, and olanzapine in patients with schizophrenia spectrum disorders: a secondary outcome analysis of a pragmatic, randomized trial (BeSt InTro);J Clin Psychopharmacol,2023
3. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;N Engl J Med,2005
4. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial;Lancet,2008
5. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial;Lancet Psychiatry,2020